2nd Annual mRNA-Based Therapeutics Summit

by Stephen Riddle

Do you want to be part of the largest gathering of mRNA professionals?

The 2nd Annual mRNA-Based Therapeutics Summit is returning in-person to Boston this July 26-28.

Expect exclusive data from the movers and shakers in mRNA vaccine and therapy development, 75+ world-class speakers, 5 dedicated tracks of content, and 45+ deep-dive case studies. Learn more here: https://ter.li/dicvhy

Here’s a snapshot of the expert speakers you can hear from:

  • ​​​​Kathy Fernando, VP, Head of Worldwide Research, Development and Medical Operations & Head of mRNA Scientific Planning, Pfizer
  • Regis Gervier, Global Head, mRNA Center of Excellence, Sanofi
  • Rituparna Das, VP – COVID Vaccines, Moderna
  • Hao Chen, Global Head of Cell & Viral Drug Substance, GlaxoSmithKline
  • Joe Payne, Founder, President & CEO, Arcturus Therapeutics
  • Pervin Anklesaria, Deputy Director, HIV Vaccines & Biologics, Bill & Melinda Gates Foundation
  • Manmohan Singh, SVP – Pharmaceutical Sciences & Delivery Technologies, Beam Therapeutics
  • Akhilesh Bhambhani, Senior Director – Biologics Drug Product Development; Tech Dev/Tech Ops, Ultragenyx
  • Liang Shang, Senior Scientist – Vaccine Analytical, Merck
  • Russell Johnson, VP – Formulation Research, RVAC Medicines
  • Tamar Grossman, Global Head – RNA & Targeted Therapeutics, The Janssen Pharmaceutical Companies of Johnson & Johnson

Download the official brochure to discover why Sanofi, Ultragenyx, Beam Therapeutics, Pfizer, Moderna, Merck, Eli Lilly, GSK, and many others have already secured their places. https://ter.li/dicvhy

This post was originally published on Source Link

You may also like